Dr. Sirbu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5000 5th Ave
Hines, IL 60141
Education & Training
- Loyola University Medical CenterResidency, Internal Medicine/Pediatrics, 2017 - 2021
- Loyola University Chicago Stritch School of MedicineClass of 2017, Doctor of Medicine, Summa cum laude
- Loyola University ChicagoBachelor of Science, Biology, Magna Cum Laude, 2007 - 2011
Certifications & Licensure
- IL State Medical License 2017 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Pediatrics Pediatrics
Publications & Presentations
PubMed
- 8 citationsA Tapered-pulsed Fidaxomicin Regimen Following Treatment in Patients With Multiple Clostridioides difficile Infection Recurrences.Andrew M Skinner, Xing Tan, Benjamin D Sirbu, Larry H. Danziger, Dale N. Gerding
Clinical Infectious Diseases. 2021-09-15 - 44 citationsVancomycin Taper and Pulse Regimen With Careful Follow-up for Patients With Recurrent Clostridium difficile Infection.Benjamin D Sirbu, Melinda M. Soriano, Carl Manzo, Jessica Lum, Dale N. Gerding
Clinical Infectious Diseases. 2017-10-15
Abstracts/Posters
- Management of Patients with Multiple Clostridioides difficile Infection Recurrences using a Tapered-Pulsed Fidaxomicin StrategyXing Tan, PharmD, Andrew M Skinner, MD, Benjamin Sirbu, MD, Larry H Danziger, PharmD, Dale N Gerding, MD, Stuart Johnson, MD, Open Forum Infectious Diseases, 12/31/2020
Research History
- Clinical ResearcherI reviewed experiences with fidaxomicin taper and pulse regimens for patients with multiple Clostridioides difficile infection recurrences that were refractory to standard therapies.2018 - 2021
- Clinical ResearcherI reviewed experiences with vancomycin taper and pulse regimens for patients with multiple Clostridium difficile infection recurrences that were refractory to standard therapies.2016 - 2017
- Undergraduate ResearcherBasic science research on synthesizing novel photosensitive compounds based on phenothiazine for use in cancer therapies2010 - 2011
Professional Memberships
- Member
- Member
- Member
- National Med-Peds Residents' Association - NMPRAMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: